These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 14208792)
1. THE EFFECT OF COMMERCIAL THROMBOLYTIC AGENTS ON EXPERIMENTAL VENOUS THROMBOSIS. RUDDICK DW; ROBERTSON HR; MERSEREAU WA J Trauma; 1964 Sep; 4():677-81. PubMed ID: 14208792 [No Abstract] [Full Text] [Related]
2. COMPARISON OF A FIBRINOLYSIN AND HEPARIN ON INDUCED VENOUS THROMBOSIS AND THROMBOLYSIS. WILLIAMS RD; KARAFFA F Surg Gynecol Obstet; 1965 Aug; 121():309-12. PubMed ID: 14320378 [No Abstract] [Full Text] [Related]
3. Fibrinolysin therapy of thrombophlebitis and pulmonary embolism--a double-blind study. SANDY JT; PERRET TS Can Med Assoc J; 1963 Jun; 88(23):1139-46. PubMed ID: 13976284 [TBL] [Abstract][Full Text] [Related]
4. THROMBOLYTIC THERAPY. DOUGLAS AS; MCNICOL GP Br Med Bull; 1964 Sep; 20():228-32. PubMed ID: 14209763 [No Abstract] [Full Text] [Related]
5. Acyl-enzymes as thrombolytic agents in dog models of venous thrombosis and pulmonary embolism. Dupe RJ; English PD; Smith RA; Green J Thromb Haemost; 1984 Apr; 51(2):248-53. PubMed ID: 6234676 [TBL] [Abstract][Full Text] [Related]
6. FIBRINOLYTIC THERAPY OF THROMBOPHLEBITIS. TWENTY-FIVE CASES STUDIED WITH SERIAL VENOGRAMS. HECKER SP Calif Med; 1964 Jul; 101(1):23-9. PubMed ID: 14179527 [TBL] [Abstract][Full Text] [Related]
7. [RESULTS OF FIBRINOLYTIC THERAPY IN EXPERIMENTAL PULMONARY EMBOLISM]. MANGIONE F; BOBBIO P Ann Ital Chir; 1965; 41():587-601. PubMed ID: 14277225 [No Abstract] [Full Text] [Related]
8. IMMUNOHISTOCHEMICAL STUDY OF THROMBOLYTIC MECHANISMS. BACK N; HIRAMOTO R; AMBRUS JL Blood; 1965 Jun; 25():1028-36. PubMed ID: 14294764 [No Abstract] [Full Text] [Related]
9. THE MANAGEMENT AND MISMANAGEMENT OF ACUTE VENOUS THROMBOSIS (THROMBOPHLEBITIS) OF THE EXTREMITIES. MORRIS LE; BALK P Angiology; 1965 Jun; 16():339-45. PubMed ID: 14294429 [No Abstract] [Full Text] [Related]
10. RADIOACTIVE (I-125) HUMAN PLASMA CLOTS FOR ASSAY OF THROMBOLYTIC ACTIVITY. HUME M J Lab Clin Med; 1964 Apr; 63():699-702. PubMed ID: 14155458 [No Abstract] [Full Text] [Related]
11. THE RATIONALE OF FIBRINOLYSIN THERAPY. MAZEL MS; BOLTON HE; RIERA R Clin Med (Northfield); 1964 Jul; 71():1175-83. PubMed ID: 15446187 [No Abstract] [Full Text] [Related]
12. EFFECTS OF FIBRINOLYTIC AGENTS AND HEPARIN ON BLOOD COAGULATION IN DOGS. LEWIS JH; SHIRAKAWA M Am J Physiol; 1964 Nov; 207():1049-52. PubMed ID: 14237448 [No Abstract] [Full Text] [Related]
13. [ACUTE VENOUS THROMBOSIS OF THE LOWER LIMBS]. SFARCICH DB Sem Med; 1964 Apr; 124():709-14. PubMed ID: 14167980 [No Abstract] [Full Text] [Related]
14. EFFECTS OF FIBRINOLYTIC AGENTS AND HEPARIN ON INTRAVASCULAR CLOT LYSIS. LEWIS JH; KERBER CW; WILSON JH Am J Physiol; 1964 Nov; 207():1044-8. PubMed ID: 14237447 [No Abstract] [Full Text] [Related]
15. USE OF DEXTRAN TO PREVENT ARTERIAL AND VENOUS THROMBOSIS. MONCRIEF JA; DARIN JC; CANIZARO PC; SAWYER RB Ann Surg; 1963 Oct; 158(4):553-60. PubMed ID: 14067503 [No Abstract] [Full Text] [Related]
16. [THROMBOLYTIC THERAPY AND CHANGES IN FIBRINOLYTIC ACTIVITY]. DOUGLAS AS; MCNICOL GP Recenti Prog Med; 1964 Sep; 37():189-217. PubMed ID: 14229145 [No Abstract] [Full Text] [Related]